Bacteriostatic Water

Quick links to important sections

Bacteriostatic Water

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bacteriostatic Water

Quick Facts

Property Description
Active ingredient Benzyl Alcohol (0.9%)
Form Sterile liquid solution (for injection)
Pharmacological class Diluent, Preservative (Bacteriostat)
Common use Reconstituting powdered injectable medicines
Origin Man-made combination product

What is Bacteriostatic Water and Why is it Used?

Bacteriostatic Water for Injection is a specialized, sterile pharmaceutical solution classified as a diluent that is used exclusively to prepare certain injectable medications. Its main purpose is to safely and accurately dissolve powdered or concentrated drugs, such as certain peptides and hormones, making them suitable for administration via subcutaneous, intramuscular, or intravenous routes.

This substance is specifically manufactured to meet strict safety and purity standards required for injectable agents, a necessity that is clinically recognized across major medical jurisdictions. The solution is recognized as a diluting agent, serving an essential role in providing a sterile vehicle for pharmaceutical preparations. This confirms that the substance is intended solely as a mixing agent for other medicines.

Composition: What Makes it "Bacteriostatic" England?

Bacteriostatic Water's composition makes it unique because it combines Sterile Water for Injection with a small amount of the preservative Benzyl Alcohol (0.9%). The core differentiating factor of this preparation is the term "bacteriostatic," which refers to the function of this active ingredient: it acts as a bacteriostat, meaning it inhibits the growth and multiplication of most bacteria.

This preservative action is necessary because repeated insertion of a needle into the vial's rubber stopper could inadvertently introduce trace amounts of bacteria into the vial. The Benzyl Alcohol safeguards the solution by preventing potential microbial contamination from spreading.

Bacteriostatic Water's Key Advantage (Multi-Dose Use)

The most practical advantage of Bacteriostatic Water is that it facilitates multi-dose usage from a single medication vial after reconstitution. The added Benzyl Alcohol preservative allows the prepared medication to be protected against microbial growth for up to 28 days following the initial access. This means the solution helps keep the medicine stable and safe for reuse over several weeks.

This feature provides significant convenience and cost-effectiveness. The preservative maintains the microbiological stability of the solution, allowing caregivers to draw up multiple small, precise doses over several weeks without compromising the safety or integrity of the final injectable product.

What side effects are possible with Bacteriostatic Water?

Possible Side Effects and Safety Information

The safety profile for Bacteriostatic Water for Injection is determined by two main regulatory focuses: adverse events common to parenteral administration and the specific risks associated with the Benzyl Alcohol preservative.

Regulatory labels do not assign standard frequency classifications (e.g., common, rare) to general adverse reactions. However, potential localized and systemic events are documented based on the administration route or the solution itself.


Documented Adverse Reactions and Systemic Risks

Adverse reactions listed in regulatory documents are usually related to the injection procedure, the solution's properties, or the active preservative.

  • Injection Site Conditions: Potential reactions include localized pain or tenderness, abscess, tissue necrosis, phlebitis (vein inflammation), and venous thrombosis (clotting) extending from the injection site.
  • General Systemic Effects: A febrile response (fever) is a documented possibility.
  • Hematological Risk: If administered intravenously without being made approximately isotonic (chemically balanced), the hypotonic solution may cause hemolysis (red blood cell destruction).

Serious Adverse Reactions and Population Restrictions

The most stringent regulatory warnings concern the Benzyl Alcohol content:

  • Gasping Syndrome: The preservative has been associated with serious, sometimes fatal, adverse events in neonates (newborns), often referred to as Gasping Syndrome. This involves severe systemic effects, including central nervous system depression, cardiovascular failure, and metabolic acidosis. Therefore, regulatory authorities severely restrict or contraindicate its use in this population.
  • Impaired Metabolism: Caution is advised when using the solution in patients with hepatic or renal impairment due to the potential for Benzyl Alcohol to accumulate and cause toxicity.

Safety Restrictions on Use

Official prescribing information includes constraints on how the solution may be used:

  • The solution must not be used for fluid replacement.
  • It is prohibited for use in epidural or spinal anesthesia procedures.

Overdose and Emergency Response

The official overdose profile for Bacteriostatic Water for Injection is determined by the toxicity of its preservative, Benzyl Alcohol (0.9%), which poses a serious risk in specific populations. Overdose presentations are characterized by symptoms of systemic toxicity, including metabolic acidosis, hypotension, Central Nervous System (CNS) depression, gasping respirations, cardio-vascular failure, and hematological anomalies.

Urgent medical help must be sought immediately upon the detection of any adverse reaction or sign of toxicity. The product must not be used in neonates or low-birth weight infants due to the documented potential for serious adverse reactions and death, and an increased incidence of Kernicterus.

In overdose circumstances, the primary emergency response requires discontinuing the infusion and initiating appropriate countermeasures. In cases of fluid overload, which is noted as an unlikely threat except possibly in very small infants, the patient must be re-evaluated for appropriate corrective measures. The cumulative daily metabolic load of benzyl alcohol must be considered, especially for patients with pre-existing liver or kidney impairment, due to the risk of preservative accumulation. The official prescribing information does not document the existence of a specific antidote for this toxicity.

Therapeutic Uses of Bacteriostatic Water

Quick Facts: Uses of Bacteriostatic Water

  • Diluent for Injectables: Indicated for use in diluting or dissolving certain powdered drugs prior to administration.
  • Administration Routes: Primarily used to prepare medications for intravenous, intramuscular, or subcutaneous injection.
  • Repeated Access: Contains a preservative to permit multiple withdrawals from a single vial over a specified time.

Bacteriostatic Water for Injection, USP, is a preparation designed exclusively to serve as a vehicle for suitable medications that require dilution or must be dissolved in an aqueous solution before they are administered by injection. The core purpose of this preparation is to aid in the dilution of injectable medications, ensuring that the drugs can be safely administered via the intended route. This use is formally indicated only for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection.

This product is particularly useful because it contains a small amount of a bacteriostatic agent, which helps to inhibit the growth of bacteria in the solution after the vial has been entered. This preservative quality allows the solution to be contained in a multiple-dose vial, making it available for repeated withdrawals when used as directed. It is a critical component in the aseptic preparation of parenteral solutions in healthcare settings.

Regulatory References

  1. FDA therapeutic overview for diluents

Eligibility and Restrictions for Use

Who Can and Cannot Use Bacteriostatic Water?

Eligibility to use Bacteriostatic Water for Injection is defined by the official regulatory status of its preservative, Benzyl Alcohol (0.9%), which imposes strict population and procedural restrictions. The solution is primarily intended for use in adult patients for the purpose of diluting suitable medications.


Contraindicated Populations and Procedures

Category Regulatory Status
Neonates (Newborn Infants) Absolutely Contraindicated due to risk of serious toxicity (gasping syndrome) from Benzyl Alcohol [FDA].
Hypersensitivity Contraindicated in patients with known sensitivity to Benzyl Alcohol [Regulatory Labeling].
Spinal or Epidural Use Contraindicated as the preservative must not be used for these procedures [FDA].

Restricted and Conditional Use

The product's safety and effectiveness have not been established in the general pediatric patient population [FDA]. Additionally, use requires caution in nursing mothers and for pregnant women, it should only be administered if clearly needed [FDA]. Patients with hepatic or renal impairment must also use the product with caution, especially when large volumes are administered, due to the risk of preservative accumulation [EMA].

What should I know about interactions with other medicines?

The documented interactions for Bacteriostatic Water for Injection are defined by the product's function as a sterile diluent and the presence of its active preservative, Benzyl Alcohol (0.9%). The product's interaction profile is not based on classic drug-drug systemic effects but on specific constraints related to the preservative and pharmaceutical stability.

Official Interaction Statements

Additive Preservative Exposure

Co-administration with other medicinal products containing benzyl alcohol is a defined interaction. Regulatory guidance specifies that the combined daily metabolic load of benzyl alcohol from all sources must be considered to avoid the risk of accumulation.

Pharmaceutical Incompatibility

The product may be chemically or physically incompatible with certain drugs for injection. Establishing the compatibility of the drug to be dissolved is required before mixing, which may necessitate using an alternative vehicle.

Interaction-Related Restrictions and Constraints

Restriction Category Constraint Basis
Neonates Use is contraindicated due to the risk of Benzyl Alcohol toxicity, including the potential for "gasping syndrome."
Spinal/Epidural Use Use is contraindicated in epidural or spinal anesthesia procedures.
Impaired Clearance Caution is advised for patients with liver or kidney impairment due to potential preservative accumulation, especially with high volumes.

Furthermore, a procedural requirement acts as a timing rule: the final admixture must be made approximately isotonic prior to intravenous use to prevent the interaction outcome of hemolysis.

Mechanism of Action

Preservative Action: Inhibiting Bacterial Cell Metabolism

The ingredient benzyl alcohol exerts its primary function by interacting with the cellular membranes and metabolic pathways of bacteria. By preferentially partitioning into the lipid bilayer, it causes membrane disruption, inhibiting essential microbial processes like respiration. This non-specific physical-chemical mechanism results in bacteriostasis, maintaining the low microbial load of the solution during repeated container access.


Osmotic Vehicle and Pharmaceutical Diluent

Sterile water acts as an inert solvent, facilitating the parenteral administration of a primary drug by enabling dissolution and concentration adjustment. Its mechanism operates through fluid dynamics and osmotic pressure. The vehicle is hypotonic, and this osmotic characteristic, if exposed directly to the bloodstream, can induce a water gradient across the cell membrane, leading to red blood cell lysis (hemolysis).


Modulating Local Sensory Nerve Signals

Benzyl alcohol possesses a secondary, incidental mechanism of local anesthetic activity. It interacts with voltage-gated sodium channels on peripheral sensory nerve endings at the injection site. This interaction stabilizes the neuronal membrane, temporarily blocking the initiation and propagation of nerve impulses, leading to the physiological consequence of attenuated pain signaling (localized blockade of nociceptive signals).

Dosage and Administration Information

Bacteriostatic Water for Injection, USP, is a pharmaceutical solution used exclusively as a sterile vehicle to dissolve or dilute certain powdered or concentrated medications prior to administration. The official use of this preparation centers entirely on its role as a diluent, as it does not possess an independent dosage regimen or therapeutic indication. Its use is formally indicated only for the preparation of drugs intended for parenteral administration, including the intravenous, intramuscular, or subcutaneous injection routes.

The required volume of Bacteriostatic Water is not standardized but must strictly follow the concentration and dose guidelines provided by the manufacturer of the primary drug being reconstituted. Due to the inclusion of 0.9% Benzyl Alcohol, the solution is characterized as bacteriostatic, a quality that allows for repeated withdrawals from a single vial. The multi-dose container is used for up to 28 days after the initial entry to prevent microbial growth.

Procedural requirements dictate that aseptic technique must be strictly employed during preparation and withdrawal to maintain the integrity of the solution. Furthermore, a specific administration condition applies to the intravenous route: the solution must not be used for IV injection unless the final admixture of the primary drug and the diluent results in an approximately isotonic preparation. The Benzyl Alcohol preservative also imposes a strict age-group restriction: the solution is contraindicated for use in neonates (newborns).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bacteriostatic Water

Evidence for its Primary Role as a Sterile Diluent

The evidence summarizes the product’s technical performance, including studies on its physicochemical compatibility with injectable medications and how research aligns with stringent regulatory manufacturing standards.

Because Bacteriostatic Water is designed solely to prepare and stabilize other medicines, research in this area was conducted primarily in laboratory settings (in vitro studies) rather than in human clinical trials. Research examined whether the solution maintains its sterile characteristics when mixed with various powdered drug substances. These findings describe patterns related to the solution's quality and sterility requirements set by major regulatory bodies.

What remains uncertain in this area is related to the specific drugs used. The results apply only to the populations studied—such as the particular drugs and concentrations tested—and comparative evidence is lacking for mixing with substances that are not explicitly approved or validated for use with this diluent.


Research on Multi-Dose Stability and Microbial Inhibition

Research explored the role of the Benzyl Alcohol component in maintaining multi-dose stability within the container after a needle has been repeatedly inserted into the stopper. Research monitored the absence of bacterial growth, an outcome monitored by studies related to microbial stability within the solution over the multi-dose period. Findings indicate patterns where the Benzyl Alcohol component was associated with the inhibition of microbial growth within the container for the specified usage time.

While the microbial inhibition characteristics was studied for short-term multi-dose stability, long-term effects are not fully established beyond the period typically associated with routine multi-dose use. The research provides insight into the characteristics of the product after the seal is broken, but there is limited information for long-term outcomes that exceed regulatory guidelines.


Evidence in Special Populations

Specific research and regulatory reviews summarized include studies evaluating systemic exposure and tolerance that have evaluated the product’s use, or defined limitations on its use, in sensitive groups like neonates and pediatric patients.

The data show patterns related to the systemic handling of Benzyl Alcohol in neonates can present risks, leading to a strong regulatory consensus that limits its application in this population. For other age groups, such as older adults, data for certain groups remain insufficient to draw broad conclusions.

Frequently Asked Questions (FAQ)

Common questions about Bacteriostatic Water (FAQ)


Q: Are there any known side effects from the preservative itself in Bacteriostatic Water?

A: Adverse reactions related to the injection of this solution may include localized tenderness or pain at the site, or a febrile response (fever), as documented in official product information. The solution is intended for use in small volumes as a diluent. Regulatory documents contain strong warnings regarding the risk of serious toxicity, known as Gasping Syndrome, if the solution is administered to neonates (newborns).


Q: Can Bacteriostatic Water be used to mix any type of medication?

A: Bacteriostatic Water is indicated for use only with certain powdered or concentrated medications. According to regulatory guidance, the solution must not be used if the primary drug is known to be incompatible with the diluent or its preservative, Benzyl Alcohol. Regulatory documents indicate that compatibility with the specific drug should be established before mixing.


Q: Does Bacteriostatic Water need to be refrigerated?

A: Official labeling mandates that unopened vials of this product be stored at Controlled Room Temperature, which is defined as 20^circ to 25 C (68^circ to 77 F). The regulatory requirements focus on maintaining product stability within this specific temperature range.


Q: Is it common to feel a mild sting when a medication mixed with Bacteriostatic Water is used?

A: Official documents list localized pain or tenderness as a possible reaction at the injection site. The preservative, Benzyl Alcohol, possesses an incidental local anesthetic property that can stabilize nerve endings, but this does not prevent all sensation. Regulatory documents do not specifically state the frequency of a 'mild sting' sensation.


Q: Can Bacteriostatic Water expire, and if so, what happens after the expiration date?

A: Yes, like all pharmaceutical products, Bacteriostatic Water has an expiration date printed on the label and must not be used past this date, even if unopened. The preservative is only validated to maintain the solution’s microbiological stability for up to 28 days after the first use, provided it is within the overall expiration period.


Q: Is it safe to travel with a reconstituted medication using Bacteriostatic Water?

A: Official documents state that the storage conditions for the final mixed drug solution must follow the specific instructions of the primary drug manufacturer. Official documents do not provide specific advice on travel storage, but emphasize that storage requirements for the final solution must be met to maintain its integrity.


Q: What should I look for to know if the water has been contaminated after opening?

A: Before each use, official instructions require that the solution must be inspected visually for clarity and the absence of particulate matter (such as cloudiness or small pieces). If the solution does not appear clear, regulatory instructions state that the product must be discarded.


Q: Can Bacteriostatic Water be used for inhalation or nebulizer solutions?

A: The product's official indications are strictly defined for preparing drugs for parenteral administration, which means injection by intravenous, intramuscular, or subcutaneous routes. Regulatory labeling does not support the use of this specific product for inhalation or nebulizer solutions.


Q: Are there specific storage temperature guidelines for an unopened vial?

A: Yes, the regulatory storage standard for an unopened vial is Controlled Room Temperature, defined as a range between 20^circ and 25 C (68^circ and 77 F). Storing within this defined range is required to ensure the stability of the solution.


Q: Are there different brands of Bacteriostatic Water, and do they contain different ingredients?

A: While various manufacturers produce this product, Bacteriostatic Water for Injection, USP must meet the strict United States Pharmacopeia (USP) standard composition. This composition includes Sterile Water for Injection and 0.9% Benzyl Alcohol as the bacteriostatic preservative. Minor concentration variations may exist based on specific regulatory approvals.


Q: Can Bacteriostatic Water cause an allergic reaction?

A: Yes. According to official product information, the solution is contraindicated (should not be used) in patients who have a known hypersensitivity or allergy to the preservative component, Benzyl Alcohol.


Q: Does the preservative concentration change over time after opening?

A: Official guidelines emphasize that the preservative, Benzyl Alcohol, is effective at maintaining microbial stability for up to 28 days after the first use. Regulatory documents do not specifically detail the chemical stability of the preservative concentration itself over this time, only its effective duration as a bacteriostat.


Q: What is the longest time a medication mixed with Bacteriostatic Water can be stored?

A: The official instruction is to use the final admixture promptly. The storage time is determined by the specific direction of the manufacturer of the powdered drug being dissolved, not by the Bacteriostatic Water itself.


Q: Can pregnant or breastfeeding individuals use medications prepared with Bacteriostatic Water?

A: Official guidance advises caution. For pregnant women, the product should only be administered if clearly needed. For nursing mothers, caution is advised because the risk of the Benzyl Alcohol preservative being passed through breast milk has not been established. This caution is based on the known risks of Benzyl Alcohol accumulation.


Q: Are there any specific patient populations where Bacteriostatic Water is not recommended?

A: Yes, it is absolutely contraindicated for neonates (newborns) due to the risk of serious toxicity (Gasping Syndrome) from Benzyl Alcohol. Caution is also advised for patients with hepatic (liver) or renal (kidney) impairment due to the potential for the preservative to accumulate in the body.


Q: Does the use of Bacteriostatic Water affect the medication's effectiveness?

A: Official documents require that the diluent be compatible with the powdered drug to maintain the physical state of the solution. Additionally, if used intravenously, the final mixture must be made isotonic (chemically balanced) to prevent cell damage. Failure to ensure compatibility or isotonicity could alter the drug’s physical state or safe administration, which is required for its safe use.


Q: Are there any known interactions between Bacteriostatic Water's ingredients and common over-the-counter supplements?

A: Official interactions focus on the risk of additive Benzyl Alcohol exposure if co-administered with other medicinal products containing the preservative. They also warn of pharmaceutical incompatibility with certain drugs. Interactions with specific over-the-counter supplements are not individually addressed in the regulatory labeling.


Q: Can I store the reconstituted medication at room temperature if it was mixed with Bacteriostatic Water?

A: Regulatory guidance specifies that reconstituted drug solutions must be stored according to the manufacturer's directions for the primary drug being dissolved. Instructions for the Bacteriostatic Water alone do not govern the storage conditions of the final mixture, which may require specific temperatures (e.g., refrigeration).


Q: Can I mix two different medications using the same vial of Bacteriostatic Water?

A: The official warning is that some drugs may be incompatible when combined in the same vehicle. Due to the risk of incompatibility, official documents discourage combining drugs in the same vehicle unless specific compatibility data exists.


Q: What is the typical volume size for a single vial?

A: The product is most commonly supplied in 30 mL multiple-dose plastic vials. This size is designed to allow for repeated withdrawals of the solution over the approved 28-day usage period.


Q: Is it acceptable for the liquid to have a faint odor?

A: The active preservative, Benzyl Alcohol, has a characteristic mild aromatic odor. Official regulatory documents do not prohibit a faint odor, but they do require that the solution be inspected visually for clarity and absence of particles before use.


Q: Do official documents specify a maximum timeframe for reconstitution?

A: Official instructions state that when diluting or dissolving drugs, the final mixture should be mixed thoroughly and used promptly. The maximum allowable storage time for the reconstituted solution is determined solely by the manufacturer of the primary drug.


Q: What is the primary concern if non-bacteriostatic water is used instead?

A: The key risk is that non-bacteriostatic water (Sterile Water for Injection) does not contain the Benzyl Alcohol preservative and is designed only for single-dose use. If it is accessed multiple times, the absence of the bacteriostat creates a high risk of microbial contamination after the first withdrawal.


Q: What are the common instructions for mixing powdered medications with this diluent?

A: Official instructions require using aseptic technique for withdrawal and mixing the final drug solution thoroughly immediately after adding the diluent. The quantity used is determined by the specific concentration and dose guidelines provided by the manufacturer of the primary drug.


Q: Does the type of syringe or needle used affect the quality of the water?

A: Regulatory guidance dictates that a fresh, sterile syringe and needle must be used for every withdrawal. This is required to maintain the sterility of the multi-dose container and ensure the aseptic technique required for safe administration.


Q: Why is it important to use a fresh, sterile syringe every time with this water?

A: Using a fresh, sterile syringe is a mandatory part of aseptic technique. This procedure is required to maintain the integrity of the solution and prevent the introduction of microbial contamination into the multi-dose vial during repeated access.


Q: Is it mandatory to use Bacteriostatic Water for all powdered injectable drugs?

A: No. Bacteriostatic Water is indicated for use only with certain powdered or concentrated medications. The specific diluent required (e.g., Sterile Water, Bacteriostatic Water, Saline) is determined by the manufacturer of the primary drug being reconstituted.


Q: Is there a maximum number of times the same vial can be accessed?

A: Official documents support repeated withdrawals from a single vial, leveraging the Benzyl Alcohol preservative to maintain stability. However, they do not specify an exact maximum number of times the vial stopper can be punctured, only that the solution must be discarded 28 days after the initial entry.


Q: What research exists about long-term use of the preservative in this type of water?

A: Research has primarily focused on the short-term microbial stability of the solution within the 28-day usage period. Official evidence documents state that long-term effects are not fully established beyond the period typically associated with routine multi-dose use.

How should Bacteriostatic Water be stored and disposed of?

Storage and Disposal Requirements

Official labeling mandates that Bacteriostatic Water for Injection, USP, be stored at Controlled Room Temperature, defined as 20° to 25°C (68° to 77°F). This required range ensures the stability of the unopened multiple-dose container.

Handling and Stability Rule Regulatory Instruction
Container Access Aseptic technique must be used for withdrawal.
Solution Check Inspect solution visually for clarity and absence of particles before use.
Post-Dilution Stability Reconstituted drug solutions must be mixed thoroughly and used promptly, and should not be stored unless directed by the solute manufacturer.

Disposal of any unused product or waste material must be done in accordance with local requirements and applicable institutional policy.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bacteriostatic Water found in:

A-Z Index: